human abuse liability assessment of e-cigarettes: Why, what and how?
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Fearon (2022)
Nicotine pharmacokinetics of electronic cigarettes: a review of the literature
Nonclinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2018)
a randomised, crossover, clinical study to assess nicotine pharmacokinetics and subjective effects of the BIDI® stick ENDS compared with combustible cigarettes and a comparator ENDS in adult smokers.
Individual Clinical
Pharmacokinetics & Abuse Liability
Pharmacokinetics
Fearon (2022)
Popcorn worker's lung: In vitro exposure to diacetyl, an ingredient in microwave popcorn butter flavoring, increases reactivity to methacholine
Nonclinical
Respiratory Toxicity
In Vitro
Fedan (2006)
Use of tobacco cessation aids and likelihood of smoking cessation: A French population-based study.
Population Clinical
Cessation
Tobacco
Fekom (2022)
Short-Term abstinence Effects in Experienced Electronic Cigarette Users.
Individual Clinical
Pharmacokinetics & Abuse Liability
Abuse Liability
Felicione (2019)
Comparing POD and MOD ENDS Users’ Product Characteristics, Use Behaviors, and Nicotine Exposure.
Population Clinical
Consumer Use
Factors Influencing Patterns Of Use
Felicione (2023)
The advantages and disadvantages of the cytokinesis-block micronucleus method
Non-clinical
Chemical
Methods
Fenech (1997)
Tackling second-hand exposure to tobacco smoke and aerosols of electronic cigarettes: the TackShS project protocol.
Individual Clinical
Respiratory Toxicity
Secondary & Tertiary Exposure
Fernández (2020)